Integrating Pharmacology and Microbial Network Analysis with Experimental Validation to Reveal the Mechanism of Composite Sophora Colon-Soluble Capsule against Ulcerative Colitis

Table 1

Number of components in CSCC with OB ≥ 30%, DL index ≥ 0.18, and Caco-2 index ≥ 0.4.

Herbs	Total	OB ≥ 30%	OB ≥ 30% and DL ≥ 0.18	OB ≥ 30%, DL ≥ 0.18, and Caco-2 ≥ 0.4
SFR	113	56	45	30
IN	29	17	9	7
BS	36	12	9	6
RS	41	15	13	4
LT	295	143	92	72